Vanda Pharmaceuticals IncAdd to My Watchlist

VNDA:USNASDAQ GMIndustry: Medical-Drugs
  • 14.95
  • 0.20  -1.32%
    Today's Change
  • 15.15
    Previous Close
  • Today
    52 Week Low - High
4:00 pm ET 10/27/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding43 million
Market Cap$647 million
Return on Equity ttm-30.39%
Last DividendVNDA:US does not pay a dividend
EPS: Year Actual ttm-0.970
EPS: Year Est. 12/16 ttm-0.437
EPS: Quarterly Actual 6/16 -0.11
EPS: Quarterly Est. 9/16 -0.08
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate--
Company Description
Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.
Revenue$110 million
Net Income$-40 million
Total Assets$213 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!